Literature DB >> 837484

Prevalence and characteristics of disproportionate ventricular septal thickening in patients with acquired or congenital heart diseases: echocardiographic and morphologic findings.

B J Maron, C E Clark, W L Henry, T Fukuda, J E Edwards, E C Mathews, D R Redwood, S E Epstein.   

Abstract

Echocardiographic and necropsy studies were performed in 304 patients with various cardiac diseases. The overall prevalence of disproportionate ventricular septal thickening (septal to free wall ratio greater than or equal to 1.3) was 10%. However, it was related to the type of cardiac lesion. Prevalence was high (greater than 20%) in pulmonary stenosis or primary pulmonary hypertension, lower (less than 15%) in Eisenmenger syndrome or aortic or mitral valvular disease and was not present in atrial or ventricular septal defect. In right ventricular overload, prevalence of disproportionate septal thickening correlated with increasing ventricular systolic pressure. None of 16 patients with disproportionate septal thickening studied at necropsy showed marked disorientation of cardiac muscle cells in the ventricular septum, characteristic of genetically transmitted asymmetric septal hypertrophy (ASH). Furthermore, disproportionate septal thickening was demonstrated by echocardiography in only one of 59 first degree relatives of patients with disproportionate septal thickening and associated cardiac diseases. Thus, disproportionate ventricular septal thickening associated with other cardiac diseases usually is due to secondary hypertrophy and is not a manifestation of genetically transmitted ASH.

Entities:  

Mesh:

Year:  1977        PMID: 837484     DOI: 10.1161/01.cir.55.3.489

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  14 in total

1.  Echocardiographic pitfalls in the diagnosis of hypertrophic cardiomyopathy.

Authors:  K Prasad; J Atherton; G C Smith; W J McKenna; M P Frenneaux; P Nihoyannopoulos
Journal:  Heart       Date:  1999-11       Impact factor: 5.994

2.  A case of hypereosinophilic syndrome with asymmetric septal hypertrophy.

Authors:  S Nunoda; A Genda
Journal:  Heart Vessels       Date:  1991       Impact factor: 2.037

3.  Asymmetric septal hypertrophy and hypertrophic cardiomyopathy.

Authors:  R Emanuel; J Marcomichelakis; R Withers; K O'Brien
Journal:  Br Heart J       Date:  1983-04

Review 4.  Myocardial disarray. A critical review.

Authors:  A E Becker; G Caruso
Journal:  Br Heart J       Date:  1982-06

5.  Prevalence, clinical correlates, and prognosis of discrete upper septal thickening on echocardiography: the Framingham Heart Study.

Authors:  Tulio Diaz; Michael J Pencina; Emelia J Benjamin; Jayashri Aragam; Deborah L Fuller; Karol M Pencina; Daniel Levy; Ramachandran S Vasan
Journal:  Echocardiography       Date:  2008-10-23       Impact factor: 1.724

6.  Histopathological specificity of hypertrophic obstructive cardiomyopathy. Myocardial fibre disarray and myocardial fibrosis.

Authors:  M G St John Sutton; J T Lie; K R Anderson; P C O'Brien; R L Frye
Journal:  Br Heart J       Date:  1980-10

7.  Specificity of systolic anterior motion of anterior mitral leaflet for hypertrophic cardiomyopathy. Prevalence in large population of patients with other cardiac diseases.

Authors:  B J Maron; J S Gottdiener; L W Perry
Journal:  Br Heart J       Date:  1981-02

8.  Heart size and function in acromegaly.

Authors:  H M Mather; M J Boyd; J S Jenkins
Journal:  Br Heart J       Date:  1979-06

9.  Nongenetically transmitted disproportionate ventricular septal thickening associated with left ventricular outflow obstruction.

Authors:  B J Maron; J S Gottdiener; W C Roberts; W J Hammer; S E Epstein
Journal:  Br Heart J       Date:  1979-03

10.  Echocardiographic differentiation of hypertensive heart disease and hypertrophic cardiomyopathy.

Authors:  Y L Doi; J E Deanfield; W J McKenna; H J Dargie; C M Oakley; J F Goodwin
Journal:  Br Heart J       Date:  1980-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.